Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: FEBS J. 2021 Dec 1;289(9):2613–2627. doi: 10.1111/febs.16291

Table 1.

Effect of UBIAD1 mutations on VKD carboxylation and MK-4 biosynthesis

Vitamin K-dependent carboxylation MK-4 synthesis, % SCD-associate mutation [24]
Activity ± SD, % EC50 ± SD, nM
WT 100 ± 2.4 3.7 ± 0.4 100 -
R54A 79.8 ± 2.6 84 ± 11.6 47.3 ± 5 -
L67Q 40.7 ± 2 3.8 ± 0.8 27.9 ± 2.3 -
N102S 98.2 ± 3 3.9 ± 0.3 82.2 ± 17 Yes
D112G 104.8 ± 3 5.1 ± 0.8 92.5 ± 3.3 Yes
D112N 109.6 ± 5.2 6.4 ± 0.6 110.3 ± 10.8 Yes
C147S 100.5 ± 3.7 3.7 ± 0.6 106.1 ± 11.2 -
G177E 117.1 ± 4.5 3.7 ± 0.5 123.3 ± 10.9 Yes
G177R 119.8 ± 1.2 3.0 ± 0.3 125.9 ± 12.9 Yes
K181A 101.7 ± 3 11.9 ± 0.4 62.3 ± 4.8 -
G186R 57.1 ± 1.1 221.1 ± 15.4 8.2 ± 6.1 Yes
D236A 32.5 ± 0.9 90 ± 17.6 3.3 ± 1.9 -
D236E 107.1 ± 4.9 22.6 ± 2.2 26.6 ± 5.4 Yes
D240A 85.6 ± 1.4 64 ± 10.5 2.6 ± 2.3 -
D240N 107.8 ± 2.5 11.2 ± 1.5 26.9 ± 8.1 Yes

Note: The activity of vitamin K-dependent carboxylation was obtained at 1 μM vitamin K3. The EC50 value was obtained using vitamin K3 concentrations from 0.015nM to 1000 nM. MK-4 synthetic activity was determined using 1 μM COT-vitamin K.